Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
forodesine (1 trial)
nitazoxanide (Alinia) (1 trial)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lymphoma (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Trials (2 total)
Trial APIs (2 total)